Reports
Reports
Sale
The global virus filtration market size was valued at USD 4.6 billion in 2023. The major drivers of the market include rising population, increased demand for biopharmaceutical drugs, and the rising prevalence of chronic diseases. The market is anticipated to grow at a CAGR of 12.3% during the forecast period 2024-2032 to reach a value of USD 13 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Virus filtration is a strong and efficient virus clearance technology, particularly used in biological manufacturing unit. The virus filtration market can be divided on the basis of segments like product, end use, and application.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry can be divided based on its product type into kits, reagents, and consumables, filtration systems, and services. Virus filtration finds its end use in the following segments:
The industry can be divided on the basis of its application as biological, medical devices, water purification, and air purification. The biological segment can be further subdivided into vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products, and stem cell products.
The EMR report looks into the regional virus filtration markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
The increased incidence of chronic diseases, including cancer, diabetes, and autoimmune disorders, will boost demand for biopharmaceutical drugs, thus, aiding the virus filtration industry globally. Biological development, such as biopharmaceutical drugs, requires extreme precision and even a small deviation in its protein structure could lead to modifications in medicine's effectiveness, quality, and safety; therefore, the use of filtration products such as chromatographic reagents, and kits is necessary to prevent the variability in protein structure or denaturation of proteins, which may adversely impact the demand for these products. The major driver, which anticipated to increase the market growth during the forecast period is the compliance of product with drug development and manufacturing regulatory frameworks such as, the Current Good Manufacturing Practice (cGMP) legislation. Intense competition among vendors is the major drawback, which may hamper the growth of the virus filtration market in the coming years.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global virus filtration market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Products |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Virus Filtration Market Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Virus Filtration Market Overview
3.1 Virus Filtration Market Historical Value (2017-2023)
3.2 Virus Filtration Market Forecast Value (2024-2032)
4 Virus Filtration Market Landscape
4.1 Virus Filtration: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Virus Filtration: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
5 Virus Filtration Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Virus Filtration Market Segmentation
6.1 Virus Filtration Market by Products
6.1.1 Market Overview
6.1.2 Filtration Systems
6.1.3 Kits, Reagents, and Consumables
6.1.4 Services
6.2 Virus Filtration Market by Application
6.2.1 Market Overview
6.2.2 Medical Devices
6.2.3 Water Purification
6.2.4 Air Purification
6.2.5 Biological
6.2.5.1 Vaccines and Therapeutics
6.2.5.2 Blood and Blood Products
6.2.5.3 Cellular and Gene Therapy Products
6.2.5.4 Tissue and Tissue Products
6.2.5.5 Others
6.3 Virus Filtration Market by End User
6.3.1 Pharmaceutical and Biotechnology Companies
6.3.2 Contract Research Organizations (CROs)
6.3.3 Others
6.4 Virus Filtration Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Virus Filtration Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Virus Filtration Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Virus Filtration Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Virus Filtration Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Virus Filtration Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Asahi Kasei Medical Co. Ltd
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Charles River Laboratories International Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Qiagen
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Pall Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck KgaA
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 General Electricity Company
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Thermo fisher Scientific
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Lonza Group Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Sartorious
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Cayman Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Virus Filtration - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global virus filtration market reached a value of USD 4.6 billion in 2023.
The market is anticipated to grow at a CAGR of 12.3% during the forecast period of 2024-2032 to reach a value of USD 13 billion by 2032.
The major drivers of the market include rising population, increased demand for biopharmaceutical drugs, and the rising prevalence of chronic diseases.
The key trends in the market include the increasing compliance of product with drug development and manufacturing regulatory frameworks.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The product types include kits, reagents, and consumables, filtration systems, and services.
The end use segments are pharmaceutical and biotechnology companies, contract research organizations (CROs), academic research organisations, and medical device companies.
The diverse applications for market are biological, medical devices, water purification, and air purification.
The major players in the market include Asahi Kasei Corporation, Charles River Laboratories International Inc., Danaher Corporation, General Electric Company, Sartorius Group, Pendotech, and Lonza Group, Merck KgaA, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.